BECKY WYNN: Open Payments
NPI 1265566640 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 117 payments from 26 companies in 2025. Trend: 2023 $1,806 · 2024 $2,064 · 2025 $2,077
Food & beverage: $2,077
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $204 |
| ABBVIE INC. | 22 | $202 |
| Novo Nordisk Inc | 8 | $188 |
| Axsome Therapeutics, Inc. | 7 | $164 |
| Corium, LLC | 6 | $159 |
| Abbott Laboratories | 7 | $149 |
| Amgen Inc. | 13 | $149 |
| Astellas Pharma US Inc | 11 | $148 |
| ABIOMED | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $88 |
Products named: Azstarys, FREESTYLE LIBRE 3, Veozah, Auvelity, EVENITY, Ozempic, VRAYLAR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
